Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311039 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Claire L Lyons und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medical Sciences, Unit of Medical Protein Science, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: ATP Binding Cassette Transporter 1, Apolipoprotein A-I, Mitochondria, Scavenger Receptors, Class B. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet, Stiftelsen för Strategisk Forskning, Novo Nordisk Fonden.
Abstract (Originalsprache)
Apolipoprotein A-I (ApoA-I), the primary component of high-density lipoprotein (HDL) cholesterol primes β-cells to increase insulin secretion, however, the mechanisms involved are not fully defined. Here, we aimed to confirm ApoA-I receptors in β-cells and delineate ApoA-I-receptor pathways in β-cell insulin output. An LRC-TriCEPS experiment was performed using the INS-1E rat β-cell model and ApoA-I for unbiased identification of ApoA-I receptors. Identified targets, alongside ATP binding cassette transporter A1 (ABCA1) (included control) were silenced in the same cells, and insulin secretion (ELISA) and mitochondrial metabolism (seahorse) were assessed with/without ApoA-I priming. Human β-cell expression data was used to investigate ApoA-I receptor pathways in type 2 diabetes (T2D). Scavenger receptor B1 (SR-BI) and regulator of microtubule dynamics 1 were identified as ApoA-I targets. SR-BI or ABCA1 silencing abolished ApoA-I induced increases in insulin secretion. ApoA-I priming increased mitochondrial OXPHOS, however this was greatly attenuated with SR-BI or ABCA1 silencing. Supporting this, human β-cell expression data investigations found SR-BI and ABCA1 to be correlated with genes associated with mitochondrial pathways. In all, SR-BI and ABCA1 correlated with 73 and 3 genes differentially expressed in T2D, respectively. We confirm that SR-BI and ABCA1 are the primary β-cell ApoA-I receptors and demonstrate that ApoA-I priming enhances β-cell insulin secretion via the upregulation of mitochondrial metabolism through ApoA-I-SR-BI and ApoA-I-ABCA1 pathways. We propose that SR-BI relies on mitochondrial and exocytotic pathways, while ABCA1 depends solely on mitochondrial pathways. Our findings uncover new targets in ApoA-I β-cell mechanism for T2D therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medical Sciences, Unit of Medical Protein Science, Lund University, Lund, Sweden.
- Department of Clinical Sciences, Unit of Islet Cell Exocytosis, Lund University Diabetes Centre, Malmö, Sweden.
- Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden.
ORCID-Profile: Jens O Lagerstedt
Förderung
- Vetenskapsrådet
- Stiftelsen för Strategisk Forskning
- Novo Nordisk Fonden
- Crafoordska Stiftelsen
- Direktör Albert Påhlssons Stiftelse
- Svenska Diabetesstiftelsen
- Kungliga Fysiografiska Sällskapet i Lund
Zitieren
APA
Lyons, C. L., Cowan, E., Nilsson, O., Mohar, M., Peña-Martínez, P., Eliasson, L., & Lagerstedt, J. O. (2024). Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells. PLOS ONE. https://doi.org/10.1371/journal.pone.0311039
Vancouver
Lyons CL, Cowan E, Nilsson O, Mohar M, Peña-Martínez P, Eliasson L, et al. Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells. PLOS ONE. 2024. doi:10.1371/journal.pone.0311039
BibTeX
@article{Lyons2024,
author = {Lyons, Claire L and Cowan, Elaine and Nilsson, Oktawia and Mohar, Manca and Peña-Martínez, Pablo and Eliasson, Lena and Lagerstedt, Jens O},
title = {Apolipoprotein A-I priming via SR-BI and ABCA1 receptor binding upregulates mitochondrial metabolism to promote insulin secretion in INS-1E cells},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311039}
}
EUVIMED